R&D fields

We conduct R&D on entire process of new drug development, namely, “Active Pharmaceutical Ingredients, Finished pharmaceutical products, platform(DDS)”. We are also pursuing the challenge of developing innovative new drugs through the fusion of bio and chemical substances.

Chemical

Active Pharmaceutical Ingredients

Development of high value-added drug substances such as antibiotics (MRSA) and antiviral drugs
Synthetic new drugs

Research on maximization of drug efficacy through development of new drug substances based on organic synthesis technology and drug combinations
Contrast agents

Development of a new x-ray contrast agents

Bio

Gene therapy drugs

Development of pDNA/mRNA/AAV, Lenti-based therapeutics for the treatment of rare, chronic, and intractable diseases
Cell therapy

Development of customized therapeutics for treatment of rare and intractable diseases Development of NK cell therapy targeted for solid tumors
Gene therapy platform/DDS

Development of a safe and effective platform including viral vector for delivering gene therapy

Drug Delivery System
(ElectroPorator, Formulation, etc)
Antibody therapy

Development of therapeutic agents with minimal side effects by acting specifically on the target

Natural Products

Natural medicine/health functional food

Natural new drug development and mass production research, and health functional food research